LBPH
Longboard Pharmaceuticals, Inc.
NASDAQHealthcareBiotechnologyUS
Company Profile
CEO
Kevin R. Lind
IPO Date
2021-03-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Longboard Pharmaceuticals, Inc.
CEO
Kevin R. Lind
IPO Date
2021-03-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| $4.40 |
| 2 Dec 2024 | SEKHRI PAUL J | director | D-Return | Disposed | 12,500 | $7.06 |
| 2 Dec 2024 | SEKHRI PAUL J | director | D-Return | Disposed | 22,500 | $18.94 |
| 2 Dec 2024 | Lynch Casey | director | D-Return | Disposed | 12,367 | $4.40 |
| 2 Dec 2024 | Lynch Casey | director | D-Return | Disposed | 12,500 | $7.06 |
| 2 Dec 2024 | Lynch Casey | director | D-Return | Disposed | 22,500 | $18.94 |
| 2 Dec 2024 | Lind Kevin Robert | director, officer: President and CEO | U-Tender | Disposed | 363,740 | $60.00 |
| 2 Dec 2024 | Lind Kevin Robert | director, officer: President and CEO | D-Return | Disposed | 255,377 | $3.12 |
| 2 Dec 2024 | Lind Kevin Robert | director, officer: President and CEO | D-Return | Disposed | 192,783 | $4.20 |